- Home
- HNST vs RCKT Comparison
HNST vs RCKT Comparison
Compare HNST & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HNST | RCKT |
|---|---|---|
| Founded | 2012 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 292.9M | 340.9M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | HNST | RCKT |
|---|---|---|
| Price | $2.68 | $3.44 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 14 |
| Target Price | $5.63 | ★ $29.12 |
| AVG Volume (30 Days) | ★ 5.3M | 2.1M |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $383,117,000.00 | N/A |
| Revenue This Year | $6.68 | N/A |
| Revenue Next Year | $4.81 | $3,582.16 |
| P/E Ratio | $44.24 | ★ N/A |
| Revenue Growth | ★ 3.89 | N/A |
| 52 Week Low | $2.31 | $2.19 |
| 52 Week High | $8.87 | $15.00 |
Technical Indicators
Market Signals| Indicator | HNST | RCKT |
|---|---|---|
| Relative Strength Index (RSI) | 41.20 | 55.63 |
| Support Level | $2.43 | $2.81 |
| Resistance Level | $2.66 | $3.07 |
| Average True Range (ATR) | 0.16 | 0.18 |
| MACD | 0.04 | 0.03 |
| Stochastic Oscillator | 57.29 | 95.31 |
Price Performance
Historical ComparisonAbout HNST The Honest Company Inc.
The Honest Co Inc is a digitally-native consumer products company to makes purpose-driven consumer products designed for all people. It is an omnichannel brand, ensuring its products are available wherever its consumers shop through the company's Retail and Digital channels. It has three product categories namely; Diapers and Wipes, Skin and Personal Care, and Household and Wellness, out of which the majority of its revenue is generated from the sale of diapers and wipes. The company operates only in the United States.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.